Literature DB >> 24821610

Association between CLOCK, PER3 and CCRN4L with non‑small cell lung cancer in Brazilian patients.

Patricia Couto1, Debora Miranda2, Renalice Vieira1, Alyne Vilhena3, Luiz De Marco1, Luciana Bastos-Rodrigues4.   

Abstract

Circadian rhythms comprise of daily oscillations in a variety of biological processes and are regulated by an endogenous clock. Disruption of these rhythms has been associated with cancer progression, and understanding natural oscillations in cellular growth control, tumor suppression and cancer treatment, may reveal how clock and clock‑controlled genes are regulated in normal physiological functioning. To investigate the association between clock genes and non‑small cell lung cancer (NSCLC), we genotyped three tag SNPs (rs938836, rs17050680, rs3805213) in the Nocturnin gene (CCRN4L), five SNPs (rs228727, rs228644, rs228729, rs707467, rs104620202) in the period 3 (PER3) gene and one SNP (rs6855837) in the CLOCK gene, in 78 Brazilian patients with NSCLC. One tag SNP in CCRN4L (rs3805213) and another tag SNP from PER3 (rs228729) demonstrated a significant correlation with genotype and allele frequency in lung cancer (P=4.4x10‑3 and P=5.7x10‑2; P=0.004 and P=0.02, respectively). The results of our study suggest these polymorphisms in the CCRN4L and PER3 genes may represent a risk factor in the occurrence and development of NSCLC in Brazilian patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24821610     DOI: 10.3892/mmr.2014.2224

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  14 in total

1.  Aberrant expression of Per1, Per2 and Per3 and their prognostic relevance in non-small cell lung cancer.

Authors:  Bin Liu; Ke Xu; Yufeng Jiang; Xiaoling Li
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

2.  Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.

Authors:  Fangyi Gu; Han Zhang; Paula L Hyland; Sonja Berndt; Susan M Gapstur; William Wheeler; The Ellipse Consortium; Christopher I Amos; Stephane Bezieau; Heike Bickeböller; Hermann Brenner; Paul Brennan; Jenny Chang-Claude; David V Conti; Jennifer Anne Doherty; Stephen B Gruber; Tabitha A Harrison; Richard B Hayes; Michael Hoffmeister; Richard S Houlston; Rayjean J Hung; Mark A Jenkins; Peter Kraft; Kate Lawrenson; James McKay; Sarah Markt; Lorelei Mucci; Catherine M Phelan; Conghui Qu; Angela Risch; Mary Anne Rossing; H-Erich Wichmann; Jianxin Shi; Eva Schernhammer; Kai Yu; Maria Teresa Landi; Neil E Caporaso
Journal:  Int J Cancer       Date:  2017-07-29       Impact factor: 7.316

Review 3.  Genetic variation of clock genes and cancer risk: a field synopsis and meta-analysis.

Authors:  Clara Benna; Charlotte Helfrich-Förster; Senthilkumar Rajendran; Halenya Monticelli; Pierluigi Pilati; Donato Nitti; Simone Mocellin
Journal:  Oncotarget       Date:  2017-04-04

4.  Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression.

Authors:  Chia-Cheng Yu; Lih-Chyang Chen; Chih-Yung Chiou; Yu-Jia Chang; Victor C Lin; Chao-Yuan Huang; I-Ling Lin; Ta-Yuan Chang; Te-Ling Lu; Cheng-Hsueh Lee; Shu-Pin Huang; Bo-Ying Bao
Journal:  Cancer Cell Int       Date:  2019-04-05       Impact factor: 5.722

5.  Circadian Gene Polymorphisms Associated with Breast Cancer Susceptibility.

Authors:  Monika Lesicka; Ewa Jabłońska; Edyta Wieczorek; Beata Pepłońska; Jolanta Gromadzińska; Barbara Seroczyńska; Leszek Kalinowski; Jarosław Skokowski; Edyta Reszka
Journal:  Int J Mol Sci       Date:  2019-11-14       Impact factor: 5.923

Review 6.  Evolving roles of circadian rhythms in liver homeostasis and pathology.

Authors:  Dexi Zhou; Yaqin Wang; Lu Chen; Leijuan Jia; Jie Yuan; Mei Sun; Wen Zhang; Peipei Wang; Jian Zuo; Zhenyu Xu; Jiajie Luan
Journal:  Oncotarget       Date:  2016-02-23

Review 7.  Evidences of Polymorphism Associated with Circadian System and Risk of Pathologies: A Review of the Literature.

Authors:  F J Valenzuela; J Vera; C Venegas; S Muñoz; S Oyarce; K Muñoz; C Lagunas
Journal:  Int J Endocrinol       Date:  2016-05-22       Impact factor: 3.257

8.  Poly(A)-specific ribonuclease and Nocturnin in squamous cell lung cancer: prognostic value and impact on gene expression.

Authors:  Panagiotis Maragozidis; Eirini Papanastasi; Diana Scutelnic; Athina Totomi; Ioanna Kokkori; Sotirios G Zarogiannis; Theodora Kerenidi; Konstantinos I Gourgoulianis; Nikolaos A A Balatsos
Journal:  Mol Cancer       Date:  2015-11-05       Impact factor: 27.401

9.  Regulatory roles of vertebrate Nocturnin: insights and remaining mysteries.

Authors:  Kelsey L Hughes; Elizabeth T Abshire; Aaron C Goldstrohm
Journal:  RNA Biol       Date:  2018-10-09       Impact factor: 4.652

10.  MassARRAY analysis of twelve cancer related SNPs in esophageal squamous cell carcinoma in J&K, India.

Authors:  Ruchi Shah; Varun Sharma; Amrita Bhat; Hemender Singh; Indu Sharma; Sonali Verma; Gh Rasool Bhat; Bhanu Sharma; Divya Bakshi; Rakesh Kumar; Nazir Ahmed Dar
Journal:  BMC Cancer       Date:  2020-06-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.